Actelion hits six-year high after favorable FDA approval for drug
ZURICH (Reuters) - Shares in Swiss group Actelion climbed more than five percent to their highest since late 2007 on Monday on optimism it has a viabl...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/I88wIgla5ns/story01.htm
No comments:
Post a Comment